Plain-English translation of NCT07076043 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This trial is testing whether young women are more likely to use HIV prevention if they have choices. Researchers are adding a new option called the dapivirine ring to existing HIV prevention programs at clinics in Kenya. The dapivirine ring is a flexible device inserted into the vagina that releases medication to help prevent HIV infection, and this study wants to see if offering it alongside daily pills encourages more women to protect themselves.
Many young women find it hard to stick with taking daily pills for HIV prevention. By offering different options—like the medication in the ring form—doctors hope more women will choose a method that fits their lives and actually use it consistently.
You likely qualify if…
You likely don't qualify if…
You will visit one of the participating clinics where you'll receive counseling about HIV prevention options. Depending on which phase the clinic is in, you may be offered standard daily oral HIV prevention medication, or you may have the choice between the daily pill and the medication-releasing ring. You'll work with clinic staff to decide which option works best for you, and the researchers will track whether you start the prevention method and how consistently you use it over time.
AI-generated summary from trial data · Jun 23, 2026 · Not medical advice
Kenya